Paraptosis‐Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer Therapy

E-ISSN： 1613-6829|14|7|smll.201702446-smll.201702446

ISSN： 1613-6810

Source： SMALL, Vol.14, Iss.7, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy

ANGEWANDTE CHEMIE, Vol. 130, Iss. 6, 2018-02 ,pp. : 1526-1529

John Wiley & Sons Inc

Access to resources Recommend Favorite

Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 57, Iss. 6, 2018-02 ,pp. : 1510-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stratification analysis of morphometric indices of populations of cancer cells with the phenotype of drug resistance

By Petunin Yu. Klyushin D. Kulik G. Yurchenko O. Todor I. Chekhun V.

Cybernetics and Systems Analysis, Vol. 41, Iss. 6, 2005-11 ,pp. : 924-931

Springer Publishing Company

Access to resources Recommend Favorite

Liposomes Assembled from a Dual Drug‐tailed Phospholipid for Cancer Therapy

CHEMISTRY - AN ASIAN JOURNAL, Vol. 10, Iss. 5, 2015-05 ,pp. : 1232-1238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia‐Induced Drug Resistance in Cancer Cells

CHEMISTRY - AN ASIAN JOURNAL, Vol. 10, Iss. 3, 2015-03 ,pp. : 642-652

John Wiley & Sons Inc

Access to resources Recommend Favorite